FOCUS. TAKE IN. OPTIMIZE.
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Oct 2025)
What this means for you
This application is over — abandoned 16 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90770052
- Mark type
- Stylized text
- Filed
- 11 Jun 2021
- Published for opposition
- 05 Apr 2022
- Abandoned
- 16 Oct 2025
- Attorney of record
- Syed Abedi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, antioxidants targeting mitochondria; dietary supplements
Owner
- Antipodean Pharmaceuticals Inc., Seattle, WA, US
- Antipodean Pharmaceuticals Inc., Seattle, WA, US
Prosecution history
- 16 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Mar 2025 — SOU EXTENSION 5 GRANTED
- 27 Nov 2024 — SOU EXTENSION 5 FILED
- 25 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 May 2024 — SOU EXTENSION 4 GRANTED
- 31 May 2024 — SOU EXTENSION 4 FILED
- 31 May 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2023 — SOU EXTENSION 3 GRANTED
- 29 Nov 2023 — SOU EXTENSION 3 FILED
- 29 Nov 2023 — SOU TEAS EXTENSION RECEIVED